These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26655610)

  • 1. Mighty MyD88 in Health and Disease.
    Pulido JS; Raja H; Vile RG; Salomao DR; Viswanatha DS
    Retina; 2016 Mar; 36(3):429-31. PubMed ID: 26655610
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
    Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
    Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.
    Tan WJ; Wang MM; Ricciardi-Castagnoli P; Tang T; Chee SP; Lim TS; Chan ASY
    Blood; 2019 Aug; 134(8):709-712. PubMed ID: 31292111
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation.
    Carreno E; Clench T; Steeples LR; Salvatore S; Lee RWJ; Dick AD; Pawade J
    Acta Ophthalmol; 2019 Feb; 97(1):e138-e139. PubMed ID: 30113125
    [No Abstract]   [Full Text] [Related]  

  • 6. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
    Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
    Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
    Raja H; Salomão DR; Viswanatha DS; Pulido JS
    Retina; 2016 Mar; 36(3):624-8. PubMed ID: 26900675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.
    Pulido JS; Salomao DR; Frederick LA; Viswanatha DS
    Retina; 2015 Apr; 35(4):624-7. PubMed ID: 25768255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary vitreoretinal lymphoma: empowering our clinical suspicion.
    Takhar JS; Doan TA; Gonzales JA
    Curr Opin Ophthalmol; 2019 Nov; 30(6):491-499. PubMed ID: 31589186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangement of immunoglobulin gene in metastatic Waldenström macroglobulinemia to the vitreous.
    Shen DF; Fardeau C; Roberge FG; LeHoang P; Chan CC
    Am J Ophthalmol; 2000 Mar; 129(3):395-6. PubMed ID: 10704566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
    Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
    Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid.
    Albitar A; Ma W; DeDios I; Estella J; Agersborg S; Albitar M
    Int J Lab Hematol; 2016 Apr; 38(2):133-40. PubMed ID: 26797804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival.
    Nagao T; Oshikawa G; Ishida S; Akiyama H; Umezawa Y; Nogami A; Kurosu T; Miura O
    Blood Cancer J; 2015 May; 5(5):e314. PubMed ID: 25978434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Waldenström macroglobulinaemia].
    Tomowiak C; Poulain S; Debiais C; Guidez S; Leleu X
    Presse Med; 2019; 48(7-8 Pt 1):832-841. PubMed ID: 31444019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
    Rajagopal R; Harbour JW
    Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
    Willenbacher W; Willenbacher E; Brunner A; Manzl C
    Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraocular lymphoma: more questions than answers.
    Wakefield D; Zierhut M
    Ocul Immunol Inflamm; 2009; 17(1):6-10. PubMed ID: 19294566
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of the MYD88 mutation by the combination of the allele-specific PCR and quenching probe methods.
    Nogami S; Kawaguchi-Ihara N; Shiratori E; Ohtaka M; Itoh M; Tohda S
    Int J Lab Hematol; 2017 Apr; 39(2):163-168. PubMed ID: 28042684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.
    Shi M; Spurgeon S; Press R; Olson S; Fan G
    Ann Hematol; 2015 Nov; 94(11):1941-4. PubMed ID: 26231802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.